| 产品名称 |
Recombinant Human VCP (C-6His) |
| 英文名称 |
Valosin-containing protein/VCP |
| 纯度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 内毒素 |
<1 EU/µg as determined by LAL test. |
| 蛋白构建 |
Recombinant Human Valosin-Containing Protein is produced by our E.coli expression system and the target gene encoding Ala2-Asn589 is expressed with a 6His tag at the C-terminus. |
| Accession |
P55072 |
| 表达宿主 |
E.coli |
| 种属 |
Human |
| 预测分子量 |
66.3 KDa |
| 制剂 |
Supplied as a 0.2 μm filtered solution of 50mM Tris-HCl, pH 8.0. |
| 运输方式 |
The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| 稳定性&储存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 复溶 |
| 分子别名 |
| Transitional Endoplasmic Reticulum ATPase; TER ATPase; 15S Mg(2+)-ATPase p97 Subunit; Valosin-Containing Protein; VCP |
| 背景介绍 |
| Valosin-Containing Protein (VCP) is a nuclear protein that belongs to the AAA ATPase family. VCP is a putative ATP-binding protein involved in vesicle transport and fusion, 26S proteasome function, and assembly of peroxisomes. It is necessary for the fragmentation of Golgi stacks during mitosis and their reassembly after mitosis. VCP has been implicated in a number of cellular events that are regulated during mitosis, including homotypic membrane fusion, spindle pole body function, and ubiquitin-dependent protein degradation. VCP participates in the formation of the transitional endoplasmic reticulum (tER) and regulates E3 ubiquitin-protein ligase activity of RNF19A. |
注意事项
本司产品仅用于科研，不用于临床诊断和治疗
